文献速递产科母胎医学

足月胎儿生长受限随机对照试验中的围产期死亡:既往风险与同意的悖论

Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-09-24

该二次分析基于足月胎儿生长受限干预试验(n=1116),比较参与者与非参与者的基线特征及母婴结局。非参与者年龄较大、BMI较低、教育水平较高、吸烟较少且更倾向期待管理,发生4例围产期死亡而参与者无死亡。非参与者中出生体重低于第3百分位的婴儿更多,期待管理的非参与者监测频率低于参与者。

要点

  • 非参与者发生4例围产期死亡,参与者无围产期死亡。
  • 非参与者中出生体重低于第3百分位的婴儿更多。
  • 期待管理的非参与者监测频率低于试验参与者。

核心结论

  • 非参与者的结局较差且围产期死亡更多。
  • 方案驱动的管理、参与者与非参与者的差异或非参与者偏好期待管理可能解释这些发现。

研究设计与样本

  • 对足月胎儿生长受限干预试验(n=1116)的参与者和非参与者进行二次分析。
  • 该试验为意向性治疗分析,比较足月胎儿生长受限孕妇的引产与期待监测,显示新生儿结局等效。
  • 以相同方式收集两组数据,比较基线特征及母婴结局。

主要发现

  • 非参与者年龄较大、BMI较低、教育水平较高、吸烟较少,且更倾向期待管理。
  • 参与者从研究纳入到临产的时间短于非参与者。
  • 非参与者中发生4例围产期死亡,参与者中无围产期死亡。
  • 非参与者中出生体重低于第3百分位的婴儿更多。
  • 期待管理的非参与者监测频率低于干预组和期待组的参与者。

关键数值与推荐

  • 主要结局为不良新生儿结局的复合指标。
  • 次要结局包括剖宫产和器械阴道分娩、新生儿重症监护病房、新生儿病房和产妇住院时间及产妇发病率。

临床怎么用

  • 临床解读足月胎儿生长受限随机试验结果时需考虑参与偏倚。
  • 对偏好期待管理且监测频率较低的非参与者应加强关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The disproportionate intrauterine growth intervention trial at term was an intention to treat analysis and compared labor induction with expectant monitoring in pregnancies complicated by fetal growth restriction at term and showed equivalence for neonatal outcomes. OBJECTIVE: To evaluate trial participation bias and to examine the generalizability of the results of an obstetrical randomized trial. STUDY DESIGN: We used data from participants and nonparticipants of a randomized controlled trial-the disproportionate intrauterine growth intervention trial at term (n=1116) -to perform a secondary analysis. This study compared induction of labor and expectant management in women with term growth restriction. Data were collected in the same manner for both groups. Baseline characteristics and neonatal and maternal outcomes were compared. The primary outcome was a composite measure of adverse neonatal outcome. Secondary outcomes were delivery by cesarean delivery and instrumental vaginal delivery; length of stay in the neonatal intensive care, neonatal ward, and the maternal hospital; and maternal morbidity. RESULTS: Nonparticipants were older, had a lower body mass index, had a higher level of education, smoked less, and preferred expectant management. The time between study inclusion and labor onset was shorter in participants than in nonparticipants. Notably, 4 perinatal deaths occurred among nonparticipants and none among participants. Among nonparticipants, there were more children born with a birthweight below the third centile. The nonparticipants who had expectant management were monitored less frequently than the participants in both the intervention and the expectant arm. CONCLUSION: We found less favorable outcomes and more perinatal deaths in nonparticipants. Protocol-driven management, differences between participants and nonparticipants, or the fact that nonparticipants had a preference for expectant management might explain the findings.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. van Wyk L, Boers KE, Gordijn SJ, et al. Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent. Am J Obstet Gynecol MFM. 2020. PMID: 33345938. doi:10.1016/j.ajogmf.2020.100239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。